Eiken Chemical CoTSE:4549 +1.45%81 EBITDA Margin % is 25.22% as of Mar. 2026, which is 45% above its 10-year median of 17.43. GuruFocus rates TSE:4549 with a GF Score™ of 81/100 and a GF Value™ of 円2,477.93 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Eiken Chemical Co ranks better than 71.2% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Eiken Chemical Co's EBITDA for the
three
months ended in Mar. 2026 was 円2,654 Mil. Eiken Chemical Co's Revenue for the
three
months ended in Mar. 2026 was 円10,522 Mil. Therefore, Eiken Chemical Co's EBITDA margin for the quarter that ended in Mar. 2026 was 25.22%.
Eiken Chemical Co (TSE:4549) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Eiken Chemical Co EBITDA Margin % Related Terms
Eiken Chemical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Eiken Chemical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4549 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Eiken Chemical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiken Chemical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Eiken Chemical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiken Chemical Co (TSE:4549) has a EBITDA Margin % of 25.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eiken Chemical Co and its competitors. This is 45% above median its historical median of 17.43. Over the past decade, Eiken Chemical Co's EBITDA Margin % has ranged from 13.72 to 24.53. According to the industry distribution chart, Eiken Chemical Co ranks #235 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 28.8%.
Is Eiken Chemical Co's EBITDA Margin % too high?
Eiken Chemical Co's current EBITDA Margin % of 25.22% is 45% above median its 10-year median of 17.43. Over the past 10 years, this metric has ranged from a low of 13.72 to a high of 24.53. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Eiken Chemical Co's value of 25.22% is 237.4% above this industry median. Based on the distribution chart, Eiken Chemical Co ranks #235 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eiken Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eiken Chemical Co ranks #235 out of 816 companies for EBITDA Margin %. This puts Eiken Chemical Co in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Eiken Chemical Co's value of 25.22% is 237.4% above this benchmark. Historically, Eiken Chemical Co's own EBITDA Margin % has ranged from 13.72 to 24.53 over the past decade. While the company's 10-year median is 17.43 vs. the industry median of 7.48, Eiken Chemical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiken Chemical Co's current EBITDA Margin % of 25.22% is 237.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eiken Chemical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiken Chemical Co's current EBITDA Margin % is 25.22%, which is 45% above median its own 10-year median of 17.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,477.93, compared to a current price of 円2,525.00 — trading 1.9% above its estimated fair value. The current EBITDA Margin % is 25.22%, which is 45% above median its 10-year median of 17.43 and 237.4% above the Medical Devices & Instruments industry median of 7.48. Eiken Chemical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current EBITDA Margin % is 25.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?
Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be overvalued.
The current stock price of 円2,525.00 is trading 1.9% above its estimated GF Value™ of 円2,477.93.
GuruFocus considers Eiken Chemical Co to be Fairly Valued.
Key valuation signals for TSE:4549:
EBITDA Margin %: 25.22% (45% above median its 10-year median of 17.43)
GF Value™: 円2,477.93 vs. price of 円2,525.00 (1.9% above fair value)
Industry Position: 237.4% above the Medical Devices & Instruments median (#235 of 816)
No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
81GF Score
Get the complete analysis for TSE:4549
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4549 has been successfully added to your 
